Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis

Journal of Autoimmunity

Volumn 10, Issue 5, 1997, Pages 491-497

  Mattalia, Alberto ^a   Lüttig, Birgit ^b   Rosina, Floriano ^c   Leung, Patrick S C ^a   Van De Water, Judy ^a   Bauducci, Marzia ^c   Ciancio, Alessia ^c   Böker, Klaus H W ^b   Worman, Howard ^d   Cooper, Ross L ^e   Manns, Michael ^b   Ansari, Aftab ^f   Rizzetto, Mario ^c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MOLINETTE HOSPITAL   (Italy)

^d The New York Presbyterian Hospital   (United States)

^e MONASH UNIVERSITY   (Australia)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BCOADC E2 branched chain alpha keto acid dehydrogenase dihydrolipoamide acetyltransferase; OGDC E2 oxoglutarate dehydrogenase complex; OLT orthotopic liver transplantation; PBC primary biliary cirrhosis; PDC E2 pyruvate dehydrogenase complex

Indexed keywords

AUTOANTIBODY; RECOMBINANT PROTEIN;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CELL NUCLEUS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LIVER TRANSPLANTATION; MALE; MITOCHONDRION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0343554627     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0156     Document Type: Article

References (27)

1. Kaplan M.M. Primary biliary cirrhosis. New Eng. J. Med. 21:1996;1570-1508.
2. Wiesner R.H., Porayko M.K., Dickson E.R., Gores G.J., LaRusso N.F., Hay J.E., Wahlstrom H.E., Kron R.A. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 16:1992;1290-1299.
3. Kilpe V.E., Krakauer H., Wren R.E. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation. 56:1993;554-561.
4. Hubscher S.G., Elias E., Buckels J.A., Mayer A.D., McMaster P., Neuberger J.M. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J. Hepatol. 8:1993;173-184.
5. Polson R.J., Portmann B., Neuberger J., Calne R.Y., Williams R. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. Gastroenterology. 97:1989;715-725.
6. Van de Water J., Gerson L.B., Ferrell L.D., Lake J.R., Coppel R.L., Batts K.P., Wiesner R.H., Gershwin M.E. Immunohistochemical evidence of disease recurrence following liver transplantation for primary biliary cirrhosis. Hepatology. 24:1996;1079-1084.
7. Esquivel C.O., Van Thiel D.H., Demetris A.J., Bernardos A., Iwatsuki S., Markus B., Gordon R.D., Marsh J.W., Makowka L., Tzakis A.G. Transplantation for primary biliary cirrhosis. Gastroenterology. 94:1988;1207-1216.
8. Buist L.J., Hubscher S.G., Vickers C., Michell I., Neuberger J., McMaster P. Does liver transplantation cure primary biliary cirrhosis? Transplant. Proc. 21:1989;2402-2402.
9. Courvalin J.-C., Worman H.J. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin. Liver Dis. 17:1997;79-90.
10. Moteki S., Leung P.S.C., Coppel R.L., Dickson E.R., Kaplan M.M., Munoz S., Gershwin M.E. Use of Designer triple expression hybrid clone for three different lipoyl domains for the detection of anti-mitochondrial antibodies. Hepatology. 24:1996;97-103.
11. Leung P.S.C., Chuang D.T., Wynn R.M, Cha S., Danner D.J., Ansari A., Coppel R., Gershwin M. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology. 22:1996;505-513.
12. Moteki S., Leung P.S.C., Dickson E.R., Van Thiel D.H., Galperin C., Buch T., Alarcon-Segovia D., Kershenobich D., Kawano K., Coppel R.L., Matuda S., Gershwin M.E. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex (OGDC-E2) in primary biliary cirrhosis using recombinant OGDC-E2. Hepatology. 23:1996;436-444.
13. Nickowitz R.E., Worman J.J. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J. Exp. Med. 178:1993;2237-2242.
14. Leung P.S., Iwayama T., Coppel R.L., Gershwin M.E. Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2. Hepatology. 12:1990;1321-1328.
15. Smith D.B., Johnson K.S. Single step purification of polypeptides expressed in Escherichia coli as fusion with glutathione-S-transferase. Gene. 67:1988;31-40.
16. Leung P.S., Van de Water J., Coppel R.L., Gershwin M.E. Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol. Res. 10:1991;518-527.
17. Surh C.D., Cooper A.E., Coppel R.L., Leung P., Ahmed A., Dickson R., Gershwin M.E. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology. 8:1988;290-295.
18. Metcalf J.V., Mitchison H.C., Palmer J.M., Jones D.E., Bassendine M.F., James O.F.W. Natural history of early primary biliary cirrhosis. Lancet. 248:1996;1399-1402.
19. Haagsma E.B., Manns M., Klein R., Grond J., Huizenga J.R., Slooff M.J., Meyer zum Buschenfelde K.H., Berg P.A., Gips C.H. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation. Hepatology. 7:1987;129-133.
20. Neuberger J., Portmann B., Macdougall B.R., Calne R.Y., Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N. Eng. J. Med. 306:1982;1-4.
21. Gouw A.S., Haagsma E.B., Manns M., Klompmaker M.J., Slooff I.J., Gerber M.A. Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors. J. Hepatol. 20:1994;500-507.
22. Adams L., Roberts S., Donovan-Brand R., Zimmer H., Hess E. Study of procainamide hapten-specific antibodies in rabbits and humans. Int. J. Immunopharmacol. 8:1993;887-897.
23. Christensen E., Neuberger J., Crowe J., Portmann B., Williams R., Altman D.G., Popper H., Doniach D., Ranek L., Tygstrup N. Azathioprine and prognosis in primary biliary cirrhosis [letter]. Gastroenterology. 90:1986;508-509.
24. Minuk G.Y. Cyclosporin A in nontransplant-related liver disease [Review]. Am. J. Gastroenterol. 84:1989;1345-1350.
25. Wiesner R.H., Ludwig J., Lindor K.D., Jorgensen R.A., Baldus W.P., Homburger H.A., Dickson E.R. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis [see comments]. New Engl. J. Med. 322:1990;1419-1424.
26. Wong P.Y., Portmann B., O'Grady J.G., Devlin J.J., Hegarty J.E., Tan K.C., Williams R. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J. Hepatol. 17:1993;284-287.
27. Van Norstrand M.D., Malinchoc M., Lindor K.D., Therneau T.M., Gershwin M.E. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 25:1997;6-11.